In this interview, CEO Sara Barrington of Verici DX – an advanced medical diagnostics firm focusing on the global kidney transplant market - takes me through today’s strong H1’24 results and multiple value catalysts ahead for the business.

00:00 Recap of #VRCI’s unique technology and USPs
05:30 Ground breaking licensing deal with Thermo Fisher Scientific.
09:35 Commercialisation of Tutivia & Protega validation test
17:00 Services, placing, cash runway & outlook

Disclosure: Verici is a Vox Markets client

свернуть